Related references
Note: Only part of the references are listed.Clinical and molecular response to dasatinib in an adult patient with Penttinen syndrome
Helena Iznardo et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2022)
Distinct functional classes of PDGFRB pathogenic variants in primary familial brain calcification
Sandrine Lenglez et al.
HUMAN MOLECULAR GENETICS (2022)
A germline mutation in the platelet-derived growth factor receptor beta gene may be implicated in hereditary progressive mucinous histiocytosis
A. Onoufriadis et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
PDGF receptor mutations in human diseases
Emilie Guerit et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Chronic Myelogenous Leukemia in Childhood
Stephanie M. Smith et al.
CURRENT ONCOLOGY REPORTS (2021)
Activating variants in PDGFRB result in a spectrum of disorders responsive to imatinib monotherapy
Tara L. Wenger et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2020)
Association of PDGFRB Mutations With Pediatric Myofibroma and Myofibromatosis
Guillaume Dachy et al.
JAMA DERMATOLOGY (2019)
Activation of Skeletal Stem and Progenitor Cells for Bone Regeneration Is Driven by PDGFRβ Signaling
Anna-Marei Bohm et al.
DEVELOPMENTAL CELL (2019)
Kosaki overgrowth syndrome: A newly identified entity caused by pathogenic variants in platelet-derived growth factor receptor-beta
Toshiki Takenouchi et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2019)
A tyrosine kinase-activating variant Asn666Ser in PDGFRB causes a progeria-like condition in the severe end of Penttinen syndrome
Cecilie Bredrup et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2019)
Recurrent PDGFRB mutations in unicentric Castleman disease
Zhaoming Li et al.
LEUKEMIA (2019)
A patient with germ-line gain-of-function PDGFRB p.N666H mutation and marked clinical response to imatinib
Dinel Pond et al.
GENETICS IN MEDICINE (2018)
Premature Aging Syndrome, Penttinen Type: Report of a Chinese Case with a PDGFRB Mutation
Zhiyong Zhang et al.
ACTA DERMATO-VENEREOLOGICA (2018)
STAT1 modulates tissue wasting or overgrowth downstream from PDGFRβ
Chaoyong He et al.
GENES & DEVELOPMENT (2017)
PDGFRB gain-of-function mutations in sporadic infantile myofibromatosis
Florence A. Arts et al.
HUMAN MOLECULAR GENETICS (2017)
Expansion of the phenotype of Kosaki overgrowth syndrome
Mari Minatogawa et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2017)
PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib
F. A. Arts et al.
ONCOGENE (2016)
Uncoupling JAK2 V617F activation from cytokine-induced signalling by modulation of JH2 αC helix
Emilie Leroy et al.
BIOCHEMICAL JOURNAL (2016)
PDGFRβ regulates craniofacial development through homodimers and functional heterodimers with PDGFRα
Katherine A. Fantauzzo et al.
GENES & DEVELOPMENT (2016)
A Point Mutation in PDGFRB Causes Autosomal-Dominant Penttinen Syndrome
Jennifer J. Johnston et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2015)
Constitutive activation of oncogenic PDGFRα-mutant proteins occurring in GIST patients induces receptor mislocalisation and alters PDGFRα signalling characteristics
Christelle Bahlawane et al.
CELL COMMUNICATION AND SIGNALING (2015)
Novel Overgrowth Syndrome Phenotype Due to Recurrent De Novo PDGFRB Mutation
Toshiki Takenouchi et al.
JOURNAL OF PEDIATRICS (2015)
Idiopathic basal ganglia calcification-associated PDGFRB mutations impair the receptor signalling
Florence A. Arts et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
PDGF receptor signaling networks in normal and cancer cells
Jean-Baptiste Demoulin et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2014)
A Recurrent PDGFRB Mutation Causes Familial Infantile Myofibromatosis
Yee Him Cheung et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
Mutations in PDGFRB Cause Autosomal-Dominant Infantile Myofibromatosis
John A. Martignetti et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
Activating ALK mutations found in neuroblastoma are inhibited by Crizotinib and NVP-TAE684
Christina Schonherr et al.
BIOCHEMICAL JOURNAL (2011)
New insights into the mechanisms of hematopoietic cell transformation by activated receptor tyrosine kinases
Federica Toffalini et al.
BLOOD (2010)
KANK1, a candidate tumor suppressor gene, is fused to PDGFRB in an imatinib-responsive myeloid neoplasm with severe thrombocythemia
S. Medves et al.
LEUKEMIA (2010)
The D816V Mutation of c-Kit Circumvents a Requirement for Src Family Kinases in c-Kit Signal Transduction
Jianmin Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Role of platelet-derived growth factors in physiology and medicine
Johanna Andrae et al.
GENES & DEVELOPMENT (2008)
Role of STAT3 in type I interferon responses - Negative regulation of STAT1-dependent inflammatory gene activation
Hao H. Ho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Isolation and characterization of a human STAT1 gene regulatory element -: Inducibility by interferon (IFN) types I and II and role of IFN regulatory factor-1
LH Wong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
